Patient Organisations in the Assessment of Cancer Treatments
The European Cancer Patient Coalition is developing an online educational module which aims to equip our members with knowledge to participate in the Health Technology Assessment (HTA) of cancer treatments.
The module will cover cancer treatments and how they are examined in these assessments, why cancer treatments might be reimbursed in some countries but not in others, and how cancer patient organisations can get involved in the HTA.
People living with cancer and their carers best understand the need for new therapies and their impact on quality of life. Their unique knowledge, perspectives and experiences are crucial in determining the value of new treatments in the Health Technology Assessment.
We need your feedback
At the ECPC Annual Congress 2018, which took place in Brussels on 8-10 June, 2018, we have presented to our members, the draft content of the ECPC HTA eLearning Module. We have also asked for our members feedback during the session.
We invite you to review the content below in more detail and provide us your feedback in the form provided.
The consultation is open until 21 June 2018.